Pre-Market Analysis on Life Technologies, Quest Diagnostics, Brookdale Senior Living, Antares Pharma, and Optimer Pharma
LONDON, April 12, 2013 /PRNewswire/ --
The Supreme Court, last year, upheld President Obama's Affordable Care Act (ACA), which is the biggest overhaul of the healthcare sector in decades. The ACA is expected to increase the number of insured individuals, which will benefit the sector. However, the reform is also expected to increase costs for the healthcare sector. Perhaps the biggest impact of the ACA in the near-term will be felt by medical instruments & supplies companies such as Antares Pharma Inc. (NASDAQ: ATRS) as they are required to pay a tax on gross sales. The ACA will also have a significant impact on medical laboratories & research companies such as Life Technologies Corp. (NASDAQ: LIFE), and Quest Diagnostics Inc. (NYSE: DGX), long-term care facilities providers such as Brookdale Senior Living Inc. (NYSE: BKD), and biotechnologies companies such as Optimer Pharmaceuticals Inc. (NASDAQ: OPTR). Healthcare stocks ended mostly higher on Thursday, tracking gains in the broad market. StockCall has posted free technical research on LIFE, DGX, BKD, ATRS, and OPTR which can be downloaded upon sign up at
http://www.stockcall.com/signup
Life Technologies Corp.'s shares edged higher yesterday. The stock closed 0.35% higher at $66.81 on above average volume of 3.58 million. Shares of LIFE have gained more than 2.20% in the last three trading sessions. The stock is currently trading close to its 52-week high of $67.92. Year-to-date, the stock has gained more than 36%, outperforming the broad market. Sign up and read the complimentary report on LIFE at
http://www.StockCall.com/LIFE041213.pdf
Shares of Quest Diagnostics Inc. rallied in trading on Thursday. The stock closed 4.42% higher at $59.83 on above average volume of 3.20 million. It also touched an intra-day high of $60 yesterday. Quest Diagnostics' shares have gained more than 5.60% in the last two sessions. The two-day rally has pushed the stock above its 50-day and 200-day moving averages, which is a bullish signal. The free report on DGX can be downloaded by signing up now at
http://www.StockCall.com/DGX041213.pdf
Shares of Brookdale Senior Living Inc. rose sharply yesterday, ending the day 2.21% higher at $28.20 on above average volume of 952,129. The stock touched an intra-day high of $28.33 in Thursday's session. The Long-Term Care Facility's shares have just moved above their 50-day moving average, which is a bullish signal. The upbeat trend is further confirmed by the stock's MACD chart. Free report on BKD can be accessed by registering at
http://www.StockCall.com/BKD041213.pdf
Shares of Antares Pharma Inc. edged higher in Thursday's session, extending its gains from the previous two trading sessions. The stock closed 1.42% higher at $3.57 on above average volume of 999,964, taking its gains in the last three sessions to nearly 3.50%. Despite the recent gains, Antares Pharma's shares have fallen 6.30% so far in 2013. The stock is currently trading more than 36% below its 52-week high. Register with StockCall and download the research on ATRS for free at
http://www.StockCall.com/ATRS041213.pdf
Shares of Optimer Pharmaceuticals Inc. rose in trading yesterday; however, the gains were limited. The stock closed 0.34% higher at $14.83 on volume of 429,780. The biotech company's shares have had an excellent run so far in 2013, gaining nearly 64%. The stock is currently trading well above its 50-day and 200-day moving averages. Read the full free research on OPTR by signing up to StockCall at
http://www.StockCall.com/OPTR041213.pdf
About StockCall.com
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at
SOURCE StockCall.com
Share this article